Branislav Bystrický

Global cancer control: responding to the growing burden, rising costs and inequalities in access

Sofía Braga, Branislav Bystrický, Camilla Qvortrup et al. · ESMO Open · 2018 · 314 citations · Full text

Public Health, Health Policy, Oncology +17

Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study

Michal Mego, Jozef Chovanec, Iveta Vochyanova-Andrezalova et al. · Complementary Therapies in Medicine · 2015 · 232 citations

Medicine, Pharmacology, Pharmacotherapy +10

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients

Michal Mego, Radoslav Danis, Jozef Chovanec et al. · Frontiers in Oncology · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +13

Primary Angiosarcoma of the Spleen: Rare Diagnosis with Atypical Clinical Course

Filip Kohútek, Ladislav Badik, Branislav Bystrický · Case Reports in Oncological Medicine · 2016 · 16 citations · Full text

Medicine, Oncology, Surgery +17